Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.
暂无分享，去创建一个
B. Yaremko | M. Lock | S. Senan | G. Bauman | A. Louie | G. Rodrigues | D. Palma | B. Ahmad | S. Gaede | Mitchell C C Liu | C. Haasbeek | A. Warner | R. Olson | N. Kopek | A. Swaminath | S. Harrow | L. Mulroy | D. Schellenberg | G. Griffioen | S. Senthi | K. Moore | S. Currie